EML4 and non-small cell lung carcinoma: To date, utility of RT-PCR based on originally designed probes (with re-sequencing) or commercially available AmoyDx EML4-ALK Fusion Gene Detection Kit (Amoy Diagnostics, China) was described in screening for ALK rearrangement in NSCLC patients [11–13].